Equillium Inc (EQ)
1.57
+0.03
(+1.95%)
USD |
NASDAQ |
May 17, 16:00
1.57
0.00 (0.00%)
Pre-Market: 20:00
Equillium Shareholders Equity (Quarterly): 21.09M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 21.09M |
| December 31, 2023 | 22.57M |
| September 30, 2023 | 24.11M |
| June 30, 2023 | 26.98M |
| March 31, 2023 | 29.27M |
| December 31, 2022 | 31.94M |
| September 30, 2022 | 28.16M |
| June 30, 2022 | 40.27M |
| March 31, 2022 | 52.63M |
| December 31, 2021 | 66.50M |
| September 30, 2021 | 75.80M |
| June 30, 2021 | 84.77M |
| Date | Value |
|---|---|
| March 31, 2021 | 91.88M |
| December 31, 2020 | 69.85M |
| September 30, 2020 | 78.13M |
| June 30, 2020 | 30.97M |
| March 31, 2020 | 36.35M |
| December 31, 2019 | 41.85M |
| September 30, 2019 | 48.96M |
| June 30, 2019 | 54.06M |
| March 31, 2019 | 59.49M |
| December 31, 2018 | 64.94M |
| September 30, 2018 | -10.38M |
| June 30, 2018 | 6.139M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
21.09M
Minimum
Mar 2024
91.88M
Maximum
Mar 2021
47.81M
Average
41.06M
Median
Shareholders Equity (Quarterly) Benchmarks
| Janux Therapeutics Inc | 655.76M |
| Mersana Therapeutics Inc | 27.98M |
| Vera Therapeutics Inc | 353.54M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.60M |
| Total Liabilities (Quarterly) | 22.50M |
| Current Ratio | 1.913 |
| Net Debt Paydown Yield | 2.20% |